Home › NDC Lookup › RxCUI directory › RxCUI 2668162

Oxaprozin 300 MG Oral Capsule — RxCUI 2668162

RxNorm drug concept · Semantic clinical drug
RxCUI 2668162 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2668162
Official nameOxaprozin 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxaprozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves pain and inflammation from osteoarthritis, rheumatoid arthritis and juvenile rheumatoid arthritis. It is an NSAID, similar in type to ibuprofen or naproxen. It treats s...
  • It is taken by mouth, usually once a day. Follow your prescriber's directions and the label. Food may slow absorption a bit but does not change how much your body gets. Do not swit...
  • Stomach upset is the most common, including constipation, diarrhea, indigestion and nausea. Some people get a rash. Mention it to your doctor if these are bothersome or persist.
  • Get emergency help for chest pain, trouble breathing, weakness on one side or signs of severe allergy. Call right away for black or bloody stools, vomiting blood, severe stomach pa...
📖 Read our full Oxaprozin guide →

🕸️ Concept Web — How Oxaprozin 300 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oxaprozin 300 MG Oral Capsule RxCUI 2668162

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxaprozin 32613
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Coxanto 2668163
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxaprozin Oral Capsule 2668161
    • Oxaprozin Oral Product 1160122
    • Oxaprozin Pill 1160123
    • Oxaprozin Oral Capsule [Coxanto] 2668167
    • Coxanto Oral Product 2668165
    • Coxanto Pill 2668166
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxaprozin 300 MG SCDC · 446924
  • Oxaprozin Oral Capsule SCDF · 2668161
  • Oxaprozin Oral Product SCDG · 1160122
  • Oxaprozin Pill SCDG · 1160123

Brand-Name Concepts

  • Oxaprozin 300 MG Oral Capsule [Coxanto] SBD · 2668168
  • Oxaprozin 300 MG [Coxanto] SBDC · 2668164
  • Oxaprozin Oral Capsule [Coxanto] SBDF · 2668167
  • Coxanto Oral Product SBDG · 2668165
  • Coxanto Pill SBDG · 2668166
  • Coxanto BN · 2668163

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2668162 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70512-0787-60 60 CAPSULE in 1 BOTTLE (70512-787-60) Oxaprozin SOLA Pharmaceuticals, LLC 2025-12-03
70512-0814-60 60 CAPSULE in 1 BOTTLE (70512-814-60) COXANTO SOLA Pharmaceuticals, LLC 2025-11-03
Observed labelers: SOLA Pharmaceuticals, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.